全文获取类型
收费全文 | 60539篇 |
免费 | 5415篇 |
国内免费 | 1483篇 |
专业分类
耳鼻咽喉 | 108篇 |
儿科学 | 1992篇 |
妇产科学 | 929篇 |
基础医学 | 4248篇 |
口腔科学 | 935篇 |
临床医学 | 6634篇 |
内科学 | 20181篇 |
皮肤病学 | 215篇 |
神经病学 | 1904篇 |
特种医学 | 789篇 |
外科学 | 3488篇 |
综合类 | 10221篇 |
现状与发展 | 7篇 |
一般理论 | 3篇 |
预防医学 | 4769篇 |
眼科学 | 1079篇 |
药学 | 6180篇 |
41篇 | |
中国医学 | 3243篇 |
肿瘤学 | 471篇 |
出版年
2024年 | 297篇 |
2023年 | 1254篇 |
2022年 | 2093篇 |
2021年 | 2948篇 |
2020年 | 2599篇 |
2019年 | 2355篇 |
2018年 | 2315篇 |
2017年 | 2259篇 |
2016年 | 2456篇 |
2015年 | 2350篇 |
2014年 | 4028篇 |
2013年 | 4622篇 |
2012年 | 3644篇 |
2011年 | 3842篇 |
2010年 | 3110篇 |
2009年 | 3018篇 |
2008年 | 2891篇 |
2007年 | 2772篇 |
2006年 | 2363篇 |
2005年 | 2126篇 |
2004年 | 1727篇 |
2003年 | 1379篇 |
2002年 | 1141篇 |
2001年 | 1098篇 |
2000年 | 883篇 |
1999年 | 731篇 |
1998年 | 663篇 |
1997年 | 602篇 |
1996年 | 532篇 |
1995年 | 482篇 |
1994年 | 474篇 |
1993年 | 455篇 |
1992年 | 387篇 |
1991年 | 348篇 |
1990年 | 319篇 |
1989年 | 301篇 |
1988年 | 290篇 |
1987年 | 233篇 |
1986年 | 231篇 |
1985年 | 233篇 |
1984年 | 266篇 |
1983年 | 125篇 |
1982年 | 210篇 |
1981年 | 151篇 |
1980年 | 172篇 |
1979年 | 103篇 |
1978年 | 84篇 |
1977年 | 85篇 |
1976年 | 61篇 |
1970年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Effect of pregnancy on the pharmacokinetics of metformin. 总被引:2,自引:0,他引:2
AIMS: To determine the effects of pregnancy on metformin pharmacokinetics. METHODS: Seven women with Type 2 diabetes mellitus taking metformin throughout pregnancy were studied on two occasions, once at 28-36 weeks gestation and once at least 8 weeks postpartum. Serum metformin concentrations were determined across a dosing interval using high-performance liquid chromatography. The areas under the serum concentration-time curve from 0 to 4 h post-dose (AUC0-4) and 0 to 8 h post-dose (AUC0-8) where possible, were compared in the pregnant and non-pregnant state. RESULTS: Metformin concentrations were lower in pregnancy in six subjects, with a mean (95% CI) AUC0-4 that was 69% (53.6, 84.8) of the postpartum value. The AUC0-4 of one subject was higher in pregnancy at 142% of the postpartum value. Overall, the mean (95% CI) AUC0-4 during pregnancy for all seven subjects was 80% (51.3, 107.8) of the postpartum value (P = 0.053, two-tailed t-test; P = 0.027, one-tailed t-test). CONCLUSION: These results are consistent with our hypothesis that the clearance of metformin increases in pregnancy as a result of enhanced renal elimination. A larger study is required to establish whether metformin dose adjustments are required in late pregnancy to maintain therapeutic effect. 相似文献
52.
目的比较强化胰岛素治疗的2型糖尿病患者在脱离胰岛素治疗和继续胰岛素治疗时的临床特点,分析脱离胰岛素的相关因素。方法统计66例入院的2型糖尿病患者的患病时间,检测开始胰岛素强化治疗、治疗过程、治疗结束时的糖化血红蛋白(HbA1 c)、体重指数(BM I)、胰岛素用量,观察脱离胰岛素所需时间。结果34例患者脱离胰岛素治疗,32例继续治疗,两组患者在年龄、治疗开始时间、BM I、HbA1 c差异均无统计学意义,而患病时间比较差异有统计学意义(P<0.05),脱离时的胰岛素用量和HbA1 c比继续治疗患者显著减低(P<0.01)。结论患病时间长短是胰岛素脱离与否的重要因素,胰岛素投入量及HbA1 c数值对脱离胰岛素与否有积极作用。 相似文献
53.
In the present investigation, the frequency and severity of periodontal disease was assessed in a group of 71 patients with a mean duration of 16.5 years of insulin-dependent diabetes mellitus (IDD). The diabetics, aged 17-63 years, were under treatment at the diabetic outpatient clinic of the III Department of Medicine, University Central Hospital of Helsinki and at two clinics of the Helsinki Health Centre. Based upon their long-term medical records, 44 individuals were assessed to have a poorly controlled insulin-dependent diabetes mellitus (PIDD). At baseline of the present study, the PIDD group had a mean blood glucose level of 11.8 mmol/l and a mean glycosylated hemoglobin (HBA1) level of 10.7%. 27 subjects were classified as having a controlled insulin-dependent diabetes mellitus (CIDD). For each individual, site-specific recordings were made for the plaque index, gingival index, pocket depth, loss of attachment, bleeding after probing, gingival recession and radiographic loss of alveolar bone. Under similar plaque conditions, adult subjects with a long-term PIDD were found to have lost more approximal attachment and bone than subjects with a CIDD (P = 0.046, P = 0.019). These differences were not equally obvious when the subjects were classified according to the history of medical complications, such as retinopathies, neuropathies and nephropathies. 相似文献
54.
Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. 总被引:2,自引:0,他引:2
Christian Delles Markus P Schneider Sebastian Oehmer Ingrid Fleischmann Erwin F Fleischmann Roland E Schmieder 《Nephrology, dialysis, transplantation》2004,19(10):2513-2518
BACKGROUND: Reactive oxygen species play a major role in the development of endothelial dysfunction. It is as yet unspecified whether increased oxidative stress contributes to endothelial dysfunction of the renal vasculature in patients with type 2 diabetes. METHODS: Renal haemodynamics were studied in 20 patients with type 2 diabetes and arterial hypertension (age 62 +/- 5 years) and 20 non-diabetic hypertensive patients at baseline and following infusions of the nitric oxide synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA; 4.25 mg/kg); the substrate of nitric oxide synthase, L-arginine (100 mg/kg); and the antioxidant, vitamin C (3 g, co-infused with L-arginine 100 mg/kg). RESULTS: The response of renal plasma flow (RPF) to L-NMMA (-54 +/- 62 and -45 +/- 42 ml/min/1.73 m(2); P = NS) and L-arginine (+46 +/- 36 and +49 +/- 25 ml/min/1.73 m(2); P = NS) was not different between diabetic and non-diabetic patients. In contrast, vitamin C induced a more pronounced increase in RPF in diabetic than in non-diabetic patients when co-infused with L-arginine (+71+/-47 and +43+/-33 ml/min/1.73 m(2); P<0.05). CONCLUSIONS: The difference in the response of renal perfusion to an antioxidant suggests increased formation of reactive oxygen species and thereby reduced nitric oxide bioavailability in the renal vasculature of patients with type 2 diabetes. 相似文献
55.
AIMS: To determine the morbidity, mortality and healthcare costs of intravenous drug-abusing patients with Type 1 diabetes (IVDA-DM), who are admitted to hospital. METHODS: Retrospective case note analysis of admissions, complications and cost estimation over a 6-year period. Each drug-abusing patient (IVDA-DM) (n = 9) was compared with two controls (n = 18) with Type 1 diabetes but without a history of intravenous drug abuse (DM-controls). Admissions were also analysed for patients with intravenous drug abuse, but without Type 1 diabetes (IVDA-controls) (n = 198). Admissions were at a University teaching hospital in Liverpool, UK. DM-controls were drawn from a population attending diabetes outpatient clinics between 1997 and 2002 at the same hospital. The main outcome measures were: the duration and healthcare costs of hospital admissions per year, outpatient attendances per year, glycated haemoglobin (HbA(1c)), weight, micro- and macrovascular complications and mortality. RESULTS: Multiple admissions, mainly related to ketoacidosis, led to marked differences in mean (95% CI) inpatient days per year per patient [IVDA-DM 28.1 (13.6-42.7) vs. DM-control 1.1 (0.2-1.9); P < 0.0001], mean inpatient days per year per patient in critical care bed (IVDA-DM 1.7 (-0.7-4.2) vs. DM-control 0; P < 0.02) and mean costs of admission, per patient per year (pound sterling 7320 vs. pound sterling 230). The IVDA-DM group frequently omitted insulin, were underweight, failed to attend as outpatients and five had died by the end of 2002. The IVDA-controls spent considerably less time in hospital [3.4 (2.8-3.9) days per patient per year]. CONCLUSION: IVDA-DM patients have higher rates of diabetes complications, are admitted more frequently and have a high mortality compared with DM and IVDA-controls. The cost of inpatient care of this small group of patients was considerable. 相似文献
56.
Summary Patients with insulin-dependent diabetes mellitus (IDDM) possess antibodies to the cytoplasmic domains of two closely related
tyrosine phosphatase-like proteins, IA-2 and phogrin, previously detected as 40 kDa and 37 kDa tryptic fragments, respectively.
A higher proportion of IDDM patients possess antibodies to IA-2 than to phogrin, and autoimmunity to phogrin might arise through
cross-reactivity with the highly homologous IA-2. In this study, we have investigated the major regions of IA-2 recognized
by antibodies in IDDM patients and examined the ability of phogrin to block antibody binding to these regions as a measure
of cross-reactivity. Analysis of antibody binding to in vitro transcribed and translated polypeptides representing different
regions of the cytoplasmic domain of IA-2 identified five different patterns of reactivity with antibodies in IDDM. Protein
footprinting analysis, whereby polypeptide fragments generated on protease treatment of immune complexes are studied, indicated
considerable heterogeneity in antibody recognition of IA-2, even between sera with similar reactivity to deletion mutants.
Blocking studies with recombinant phogrin indicated that IA-2 antibodies recognize epitopes that are both unique to IA-2 and
shared with phogrin. The amino-terminal 150 amino acids of the cytoplasmic domain of IA-2 encompass epitopes that are not
represented on phogrin, whereas shared epitopes are localized within the carboxy-terminal 220 amino acids. The results demonstrate
considerable heterogeneity between IDDM patients in autoantibody recognition of IA-2 in IDDM, whereas antibody recognition
of phogrin is restricted in most patients to epitopes also present on IA-2. [Diabetologia (1997) 40: 1327–1333]
Received: 4 April 1997 and in revised form: 2 July 1997 相似文献
57.
报告5例对胰岛素抵抗的糖尿病特殊类型病例,其均具有胰岛素应用指征,但使用胰岛素后血糖却反而上升,逐渐增加胰岛素用量,则血糖值亦呈上升趋势。对该类病人的治疗,首先停用胰岛素,改用自制中药制剂及优降糖、降糖灵治疗,取得了良好效果。 相似文献
58.
六味地黄汤对实验性糖尿病大鼠心、肝、肾组织中过氧化氢酶活性和过氧化脂质含量的影响 总被引:7,自引:0,他引:7
用四氧嘧啶诱导雄性Wistar大鼠为模型进行研究.结果发现,四氧嘧啶大鼠血糖明显升高,且心、肝、肾组织中过氧化氢酶活性较正常组明显降低,过氧化脂质含量在心、肝组织中明显增高,过氧化脂质与过氧化氢酶比值在心、肝、肾组织中均明显高于正常组,表明糖尿病状态下大鼠心、肝、肾组织中均自由基生成增多,氧化损伤加重.经六味地黄汤治疗后,血糖明显下降,但心、肝、肾组织中的过氧化氢酶活性无改变;而心肌中过氧化脂质含量和过氧化脂质与过氧化氢酶比值则明显降低,过氧化脂质含量和过氧化脂质与过氧化氢酶比值在肝、肾组织中无变化,表明六味地黄汤能明显清除心肌中自由基,抑制心肌中脂质过氧化,且此作用并不是通过提高过氧化氢酶活性来达到. 相似文献
59.
60.
A prospective hearing survey was performed in a sample of 102 diabetic patients. The hearing data were compared with the hearing thresholds of three control population groups. A significant difference was found in the average hearing thresholds between the diabetic patients and all of the three control populations. Diabetic patients have worse hearing threshold levels especially at low and mid frequencies (P < 0.001). There was also a correlation between the duration of diabetes and hearing loss. No significant correlation was found between the different stages of diabetic retinopathy and the degree of hearing loss. 相似文献